ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,265.72
-0.78%
Dow Jones
39,054.80
-1.55%
US Dollar vs MXN
16.7364
0.43%
Brent Oil
81.155
-0.46%
Bitcoin
67,339.95
-2.55%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Frequency Therapeutics Inc (FREQ)

  7. Frequency Therapeutics Inc (FREQ) Noticias

FREQ

Frequency Therapeutics (FREQ)

Frequency Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FREQ
FechaHoraFuenteTítuloSímboloCompañía
01/05/202416:18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202406:47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FREQFrequency Therapeutics Inc
29/04/202406:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
26/04/202415:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
24/04/202418:33Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
24/04/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
22/04/202416:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
22/04/202416:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
19/04/202415:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
27/03/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
26/03/202416:09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FREQFrequency Therapeutics Inc
26/03/202416:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
26/03/202415:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FREQFrequency Therapeutics Inc
06/11/202316:22Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FREQFrequency Therapeutics Inc
02/11/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FREQFrequency Therapeutics Inc
25/10/202315:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
28/09/202305:06Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
21/08/202314:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FREQFrequency Therapeutics Inc
10/08/202315:01Business WireFrequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial ResultsNASDAQ:FREQFrequency Therapeutics Inc
27/07/202316:28Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
14/07/202305:30Business WireKorro Bio and Frequency Therapeutics Announce Merger AgreementNASDAQ:FREQFrequency Therapeutics Inc
13/07/202314:43Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
12/07/202320:25Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
20/06/202315:34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:FREQFrequency Therapeutics Inc
06/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FREQFrequency Therapeutics Inc
12/05/202315:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FREQFrequency Therapeutics Inc
12/05/202315:01Business WireFrequency Therapeutics Provides Business Updates and First Quarter 2023 Financial ResultsNASDAQ:FREQFrequency Therapeutics Inc
01/05/202315:17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FREQFrequency Therapeutics Inc
10/03/202306:42Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FREQFrequency Therapeutics Inc
10/03/202306:30Business WireFrequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:FREQFrequency Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FREQ

Su Consulta Reciente

TSXV
HPQ
HPQ Silicon
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados